2003年毕业于哈尔滨医科大学获肿瘤学硕士学位,2009年获该专业博士学位;后于2007年赴美国康奈尔大学从事食品抗癌机制研究,2016年赴美国Avera Cancer Center进修肿瘤精准医学。从事肿瘤异质性及转移机制研究。主持国家和省部级科研项目8项,包括国家自然科学基金项目、教育部春晖计划项目、中国博士后科学基金项目、黑龙江省自然科学基金项目、黑龙江省青年基金项目等。发表SCI论文16篇、国家核心期刊论文28篇。获中国抗癌协会科技奖二等奖1项,黑龙江省政府科技进步一等奖1项、二等奖2项、三等奖2项。
联系方式:kangxm28@xmu.edu.cn
代表性成果
1. Liu Y, Zou T, Wang S, Chen H, Su D, Fu X, Zhang Q, Kang X. Genisteininduced differentiation of breast cancer stem/progenitor cells through a paracrine mechanism. International Journal of Oncology, 2016, 48(3):1063-72.
2. Zhang QY, Wang SH, Huang X, Jin S, Kang XM. Effect of soy isoflavones on breast cancer recurrence and death for patients receiving adjuvant endocrine therapy CANADIAN MEDICAL ASSOCIATION JOURNAL 2010, 182(17):1857-62.
3. Jin S, Zhang QY, Kang XM. Antitumor and Antiangiogenic Activity of Soy Phytoestrogen on 7,12-Dimethylbenz[alpha]anthracene-Induced Mammary Tumors Following Ovariectomy in Sprague-Dawley Rats JOURNAL OF FOOD SCIENCE 2009, 74(7): 648-53.
4. Guo X, An W, Niu X, Li S, Liu Z, Yang Y, Wang N, Jiang Q, Kang X, Yan C, Wang H, Zhang Q. Photothermal therapeutic application of gold nanorods -porphyrin-trastuzumab complexes in HER2-positive breast cancer. Scientific Reports. 2017: 42069.
5. Wang H, Wang L, Song Y, Wang S, Huang X, Xuan Q, Zhang Q, Kang X. CD44+/CD24 phenotype predicts a poor prognosis in triple negative breast cancer,Oncol Letters 2017, 14(10): 5890-8.